Hikma Pharmaceuticals (LSE:HIK) Short-Term Debt : £119 Mil (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Hikma Pharmaceuticals Short-Term Debt?

Hikma Pharmaceuticals's Short-Term Debt for the quarter that ended in Dec. 2023 was £119 Mil.

Hikma Pharmaceuticals's quarterly Short-Term Debt increased from Dec. 2022 (£114 Mil) to Jun. 2023 (£167 Mil) but then declined from Jun. 2023 (£167 Mil) to Dec. 2023 (£119 Mil).

Hikma Pharmaceuticals's annual Short-Term Debt increased from Dec. 2021 (£84 Mil) to Dec. 2022 (£114 Mil) and increased from Dec. 2022 (£114 Mil) to Dec. 2023 (£119 Mil).

Hikma Pharmaceuticals Short-Term Debt Historical Data

The historical data trend for Hikma Pharmaceuticals's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hikma Pharmaceuticals Short-Term Debt Chart

Hikma Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

Get a 7-Day Free Trial

434.15

117.55

84.22

114.12

118.50

Hikma Pharmaceuticals Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Short-Term Debt	Get a 7-Day Free Trial															84.22	103.94	114.12	167.11	118.50

Hikma Pharmaceuticals Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Hikma Pharmaceuticals Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Hikma Pharmaceuticals's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Hikma Pharmaceuticals (LSE:HIK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hikma Pharmaceuticals PLC (LSE:HIK) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

HKMPY:USA HKMPF:USA HIKl:UK H5P:Germany

Address

1 New Burlington Place, London, GBR, W1S 2HR

Website

https://www.hikma.com

Hikma Pharmaceuticals PLC is engaged in the development, manufacture, and marketing of a broad range of generic, branded, and in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. The majority of the company's sales are based in the U.S. and to a lesser degree in the Middle East, North Africa, and Europe.

Hikma Pharmaceuticals (LSE:HIK) Headlines

No Headlines